latestmarketingreports

 The Gonorrhea Diagnostics Market  is estimated to reach $13.6 billion by 2028, growing at a CAGR of 8.9% over the forecast period 2023-2028. Gonorrhea is a sexually transmitted infection afflicted by a bacterium that can affect both genders. Most often, gonorrhea impacts the urethra, rectum or throat. The recommended treatment for gonorrhea includes fluoroquinolone and ciprofloxacin. Cephalosporins, ceftriaxone (intramuscular) or cefixime (oral) are the recommended alternatives. However, recent audit data reveal other cephalosporins, including cefuroxime (intramuscular or often oral), that are currently being used to treat gonorrhea. Gonorrhea can also infect the cervix in females. Most frequently, gonorrhea is spread through vaginal, oral or anal intercourse. But after childbirth, newborns of infected mothers can contract the disease. Gonorrhea most frequently damages the eyes in infants. According to the Women’s Health & STIs article, for vaginal infections, traditional...

  The Gonorrhea Diagnostics Market is estimated to reach  $13.6 billion by 2028 , growing at a  CAGR of 8.9%  over the forecast period 2023-2028. Gonorrhea is a sexually transmitted infection afflicted by a bacterium that can affect both genders. Most often, gonorrhea impacts the urethra, rectum or throat. The recommended treatment for gonorrhea includes fluoroquinolone and ciprofloxacin.  Cephalosporins , ceftriaxone (intramuscular) or cefixime (oral) are the recommended alternatives. However, recent audit data reveal other cephalosporins,   including cefuroxime (intramuscular or often oral),  that are currently being used to treat gonorrhea. Gonorrhea can also infect the cervix in females. Most frequently, gonorrhea is spread through vaginal, oral or anal intercourse. But after childbirth, newborns of infected mothers can contract the disease. Gonorrhea most frequently damages the eyes in infants. According to the Women’s Health & STIs article,...